An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?

• Autors principals: Parkinson Lynne (Autor), Doljagore Xenia (Autor), Gibson Richard (Autor), Doran Evan (Autor), Notley Lisa (Autor), Stewart Williams Jenny (Autor), Kowal Paul (Autor), Byles Julie E (Autor)
• Format: Llibre
• Publicat: BMC, 2011-11-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>When a medicine such as rofecoxib (Vioxx) is withdrawn, or a whole class of medicines discredited such as the selective COX-2 inhibitors (COX-2s), follow-up of impacts at consumer level can be difficult and costly. The Australian Lon...